Flerie Invest invests heavily in life science

Report this content

In the past year, investment company Flerie Invest has almost doubled the number of life science companies in its portfolio, which currently holds about 30 companies. A driving factor is that the man behind the company – Thomas Eldered – sold his entire holding in the successful company Recipharm in 2021, thereby freeing up significant capital for new investments. BioStock talked to Thomas Eldered about his investment strategy.

Read the full article at biostock.se:


This is a press release from BioStock - Connecting Innovation & Capitalhttps://www.biostock.se/en/


Documents & Links

Quick facts

Flerie Invest invests heavily in life science
Tweet this